Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-08-06Clinical Trial Update: Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease [Phase 2]
A Phase 2 trial evaluating interferon beta-1a (Rebif) for Crohn's disease was terminated. The update covers safety and efficacy results from…
-
CLINICAL_TRIALS trial_result · 2013-07-31Clinical Trial Update: A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's Disease [Phase 2]
Phase 2 study evaluating the safety and efficacy of ustekinumab (CNTO 1275) in Crohn's disease has completed, with results posted in 2013.
-
FDA approval · 2013-07-23FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Pentasa (mesalamine) from Takeda Pharmaceuticals America, Inc. The action involves an update to …
-
CLINICAL_TRIALS trial_result · 2013-07-16Clinical Trial Update: Contrast Ultrasound of the Small Intestine in Patients With Crohns Disease
A completed clinical trial evaluated contrast ultrasound of the small intestine in people with Crohn's disease.
-
CLINICAL_TRIALS trial_result · 2013-07-04Clinical Trial Update: A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease [Phase 3]
A follow-on safety study in Crohn's disease patients previously withdrawn from a double-blind study due to Crohn's exacerbation; Phase 3 com…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-01Clinical Trial Update: Vitamin D Supplementation in Crohn's Patients [Phase 1]
This entry reports the completion of a Phase 1 clinical trial evaluating vitamin D supplementation in Crohn's disease patients, with results…
-
CLINICAL_TRIALS research · 2013-06-27Clinical Trial Update: Personality Traits and Its Impact on Quality of Life and Clinical Outcome Evaluation in Crohn's Patients [NA]
This clinical trial update examines how personality traits influence quality of life and clinical outcomes in patients with Crohn's disease;…
-
CLINICAL_TRIALS research · 2013-06-19Clinical Trial Update: A RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing
A retrospective data collection study evaluating compression anastomosis with the ColonRing device, sponsored by novoGI. The current trial s…
-
CLINICAL_TRIALS research · 2013-06-05Clinical Trial Update: Data Collection of Patients Treated With the ColonRing™ for the Creation of Circular Compression Anastomosis
This clinical trial update reports ongoing data collection on patients treated with the ColonRing circular compression anastomosis device.
-
CLINICAL_TRIALS research · 2013-06-04Clinical Trial Update: Efficacy Study of T2 Versus AZA to Maintain Clinical and Endoscopic Remission in Postoperative Crohn's Disease [NA]
This entry describes a clinical trial comparing T2 to azathioprine for maintaining postoperative remission in Crohn's disease. The status of…
-
CLINICAL_TRIALS trial_result · 2013-05-30Clinical Trial Update: The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's Disease [Phase 2]
Phase 2 trial evaluating low dose naltrexone for Crohn's disease in children has completed and results posted in 2013.
-
FDA approval · 2013-05-24FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
The FDA approved a Biogen supplemental application for TYSABRI (Natalizumab). The action indicates a modification/expansion of the product l…
-
CLINICAL_TRIALS trial_result · 2013-05-20Clinical Trial Update: Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease [Phase 1]
Phase 1 trial evaluating safety and tolerability of a single oral dose of CNDO-201 Trichuris suis ova in Crohn's disease patients. Results w…
-
CLINICAL_TRIALS trial_result · 2013-05-17Clinical Trial Update: The Effects of Naltrexone on Active Crohn's Disease [Phase 2]
Phase 2 trial update evaluating the effects of naltrexone in active Crohn's disease; results posted after completion.
-
FDA approval · 2013-05-14FDA Approved: MERCAPTOPURINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for mercaptopurine from Mylan Pharmaceuticals Inc., authorizing a generic version under an appro…
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease [Phase 2]
Phase 2 trial results in Crohn's disease evaluating ciprofloxacin to prevent postoperative endoscopic recurrence after surgery, with the stu…
-
FDA approval · 2013-04-29FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab from Janssen Biotech, expanding its labeling and indications.
-
FDA approval · 2013-04-24FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS trial_result · 2013-04-18Clinical Trial Update: Colesevelam for the Treatment of Bile Acid Malabsorption in Patients With Crohn's Disease [Phase 4]
A Phase 4 trial evaluating colesevelam for bile acid malabsorption in Crohn's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2013-04-16Clinical Trial Update: Cannabidiol for Inflammatory Bowel Disease [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating cannabidiol for inflammatory bowel disease, including Crohn's disease and ulcerative colitis…
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: EPANOVA in Crohn's Disease, Study 1 [Phase 3]
This document reports the completion status of a Phase 3 study of EPANOVA for Crohn's disease conducted by Tillotts Pharma.
-
CLINICAL_TRIALS trial_result · 2013-04-04Clinical Trial Update: The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD) [NA]
A clinical trial registry entry from Jinling Hospital, China investigates whether enteral nutrition can help maintain remission after Crohn'…
-
CLINICAL_TRIALS research · 2013-03-28Clinical Trial Update: Efficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction Remission [NA]
A clinical trial update describes an efficacy study of Tripterygium glycoside combined with enteral nutrition for inducing remission in Croh…
-
CLINICAL_TRIALS research · 2013-03-26Clinical Trial Update: Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease [Phase 3]
A Phase 3 clinical trial is evaluating whether adding azathioprine to Cimzia improves outcomes in active Crohn's disease; current status is …
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients [Phase 4]
A Phase 4 clinical trial evaluated the immunogenicity of a Hepatitis A vaccine in patients with inflammatory bowel disease, including Crohn'…